CSL (ASX:CSL) - Fundamentals

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code CSL	Name CSL Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 478,911,979	Shares Floated 481,754,750	Held by Insiders 0.031%	Held by Institutions 40.743%

Directors & Officers

Name & Education	Position
Mr. Gordon Naylor BEng (Hons), C.P.A., DipCompSc, M.B.A.	CEO, MD & Director
Mr. Ken Lim	Chief Financial Officer
Dr. Mary Oates Ph.D.	Executive VP & COO
Mr. Mark Dehring	Head of Investor Relations
Mr. Gregory Boss B.S., BS(Hons), J.D.	Executive VP of Legal & Group General Counsel
Ms. Amy Van Buren	Chief People Officer
Dr. William Mezzanotte M.D., M.P.H.	Chief Medical Officer, Executive VP and Head of Research & Development
Mr. Stephen Marlow	Executive VP & GM of CSL Plasma
Mr. Mark Hill B.A., M.B.A.	Chief Digital Information Officer & Executive VP
Ms. Deirdre BeVard	Senior Vice President of Research & Development Strategic Operations

CSL Historic Dividends

Date	Amount
7 March 2022	$1.42290
2 September 2021	$1.58965
4 March 2021	$1.34142
10 September 2020	$1.46958
11 March 2020	$1.47127
10 March 2020	$1.47127
10 September 2019	$1.45455
13 March 2019	$1.20317
12 March 2019	$1.20317
11 September 2018	$1.27819
14 March 2018	$1.00496
13 March 2018	$1.00496
12 September 2017	$0.91530
15 March 2017	$0.83776
14 March 2017	$0.83776
13 September 2016	$0.88665
23 March 2016	$0.81470
22 March 2016	$0.81470
7 September 2015	$0.89991
16 March 2015	$0.74385
15 March 2015	$0.74385
8 September 2014	$0.64850
5 March 2014	$0.58880
4 March 2014	$0.58880
9 September 2013	$0.56980
5 March 2013	$0.48660
4 March 2013	$0.48660
17 September 2012	$0.47000
14 March 2012	$0.36000
13 March 2012	$0.36000
19 September 2011	$0.45000
8 March 2011	$0.35000
7 March 2011	$0.35000
13 September 2010	$0.45000
9 March 2010	$0.35000
8 March 2010	$0.35000
14 September 2009	$0.40000
10 March 2009	$0.30000
9 March 2009	$0.30000
16 September 2008	$0.23000
14 March 2008	$0.23000
13 March 2008	$0.23000
17 September 2007	$0.55000
14 March 2007	$0.49000
13 March 2007	$0.49000
18 September 2006	$0.40000
14 March 2006	$0.28000
13 March 2006	$0.28000
30 August 2005	$0.30000
8 March 2005	$0.17000
7 March 2005	$0.17000
20 September 2004	$0.26000
29 March 2004	$0.12000
22 September 2003	$0.22000
31 March 2003	$0.12000
20 September 2002	$0.22000
5 April 2002	$0.12000
21 September 2001	$0.17000
5 April 2001	$0.09000
22 September 2000	$0.15000
21 September 2000	$0.15000
6 April 2000	$0.08000
27 September 1999	$0.14000
8 April 1999	$0.07000
25 September 1998	$0.12000
7 April 1998	$0.06000
31 October 1997	$0.10000
30 October 1997	$0.10000
11 April 1997	$0.05500
1 November 1996	$0.08000
31 October 1996	$0.08000
15 April 1996	$0.05000
9 November 1995	$0.07000
8 November 1995	$0.07000
27 March 1995	$0.05000
8 November 1994	$0.05000
7 November 1994	$0.05000

End of Day Prices

Date	Close	Volume	Change
18-Sep	$198.34	2,097,346	-9.48 (4.56%)
12-Sep	$207.82	1,061,162	+2.01 (0.98%)
11-Sep	$205.81	1,481,808	-3.44 (1.64%)
05-Sep	$209.25	1,145,142	-1.60 (0.76%)
04-Sep	$210.85	1,184,425	+4.23 (2.05%)
03-Sep	$206.62	1,235,226	-6.27 (2.95%)
29-Aug	$212.89	1,120,057	+0.19 (0.09%)
28-Aug	$212.70	788,032	-3.90 (1.80%)
22-Aug	$216.60	2,451,697	-9.40 (4.16%)
21-Aug	$226.00	2,278,663	-44.37 (16.41%)
15-Aug	$270.37	600,591	+0.27 (0.10%)
14-Aug	$270.10	499,742	+4.57 (1.72%)
07-Aug	$265.53	642,872	-5.37 (1.98%)
31-Jul	$270.90	1,068,920	-0.21 (0.08%)
30-Jul	$271.11	653,979	-0.89 (0.33%)
5 up, 10 down, and 0 flat days

High $278.08	Low $276.68	Trades 24,705	Turnover $270,464,856	Volume 970,129
30 June 2023 at 4:22pm

Market Cap (19-Sep) $97,192,042,496	EBITDA $4,840,000,000	PE 12.44	Book Value $55.27
Dividend per Share $2.92	Dividend Yield 2.59%	EPS $8.81	Profit Margin 9.06%
Operating Margin 31.65%	ROA 6.58%	ROE 6.66%	Revenue (FY) $15,406,999,552
Revenue per Share $31.84	Gross Profit (FY) $7,992,000,000	Q' YOY Revenue Growth 1.8%	Q' YOY Earnings Growth 80.1%

High $278.08	Low $276.68	Trades 24,705	Turnover $270,464,856	Volume 970,129
30 June 2023 at 4:22pm

CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

$277.38 -0.92 (-0.33%)

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

CSL Historic Dividends

$277.38 -0.92 (-0.33%)

Followers

Prices

Announcements

End of Day Prices

CSL Health Care Biopharmaceutical Blood Healthcare Immunodeficiency Plasma

$277.38 -0.92 (-0.33%)

Stock Information

Technicals

Financial Snapshot (December 2025)

Directors & Officers

CSL Historic Dividends

$277.38 -0.92 (-0.33%)

Followers

Prices

Announcements

End of Day Prices

CSL Health Care
Biopharmaceutical Blood Healthcare Immunodeficiency Plasma